ReferenceGrowth-hormone secretagogue research
Ipamorelin
NNC 26-0161 · pentapeptide secretagogue
Selective ghrelin-receptor secretagogue studied in growth-hormone-axis research.
About Ipamorelin
Ipamorelin is a selective pentapeptide ghrelin-receptor (GHS-R) agonist studied in somatotropic-axis research for its selective growth-hormone-release profile with minimal effect on other hormones. It is a common reference secretagogue. TagPep is adding ipamorelin as a research-use-only reference material.
Mechanism studied in research
Selective agonism of the ghrelin/GHS receptor, studied for pulsatile growth-hormone release in model systems without strongly affecting cortisol or prolactin.
Areas of research investigation
- GH-secretagogue receptor assays
- Somatotropic-axis research
- Pulsatile-release model systems
- Comparative secretagogue selectivity
Laboratory handling
Lyophilized; reconstituted with bacteriostatic or sterile water for research, refrigerated solution, frozen light-protected powder.
Ipamorelin research FAQ
Why is ipamorelin often paired with CJC-1295?
The two act on different parts of the GH axis — CJC-1295 on the GHRH receptor and ipamorelin on the ghrelin receptor — so they are frequently studied together in research.
Is ipamorelin selective?
It is studied as one of the more selective GH secretagogues, with comparatively little effect on cortisol or prolactin in model systems.
Research use only. Ipamorelin is supplied as a laboratory reference material for in-vitro and research applications. It is not a drug, supplement or medical product, and is not intended for human or veterinary use, consumption, or clinical application.